We are reinventing the fundamental science underlying the development of new medicines and their use in individual patients.
The Laboratory of Systems Pharmacology (LSP) uses a team science approach to advance the fundamental science and technology needed to develop new medicines and personalized patient care.
We study the molecular causes of disease, how drugs exert their therapeutic and adverse effects, how clinical trials are designed and interpreted, and how machine learning and AI can help identify new molecular targets in diseases like cancer, Alzheimer’s, tuberculosis, and chronic pain.
The LSP is a research and education program that is part of the Harvard Program in Therapeutic Science (HiTS). Our organization prepares students and fellows for leadership roles in academic research, industry, and government service.
Explore LSP Research
Twitter @Harvard_Lab
🌟Thrilled to see this groundbreaking research from Karen Cichowski's lab @BrighamWomens published!
We are proud to have been part of the team. Browse the primary tissue images from the manuscript here:
Team led by Ludwig Harvard's Karen Cichowski has identified in preclinical studies a 2-drug combo that could treat #TNBC. It kills cancer cells by hijacking naturally occurring signals that eliminate certain breast cells after the cessation of lactation https://bit.ly/3ZWFRQW
Alex's research has allowed us to peer into tumors in a way that we never thought was possible - his talk will surely be stunning! 🔬💫
Team Pathology is walking Now in the @TheJimmyFund Walk!! Donate now to help fund cancer research!
3
Join us on Monday @harvardmed at 3PM for two fantastic discussions focusing on cell death in radiation therapy and breast cancer metastasis!